Catherine Prescott

Avlar Ltd. (Avlar BioVentures) is a venture capital firm founded in 1999 by Alan Goodman and Daniel Roach. The firm is headquartered in Cambridge, United Kingdom.

CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom.

Videregen Ltd. operates a regenerative medicine company created to address the chronic shortage of organs for transplantation in the field of tissue decellularisation, regenerative technologies and translation from laboratory to market. Its platform technology uses decellularised organ scaffolds seeded with the patient’s own cells to create non-immunogenic, regenerative bespoke organ replacements. The company was founded by Stephen Bloor in 2011 and is headquartered in Liverpool, The United Kingdom.

Babraham Institute operates as charitable life sciences organization. It is a registered charity, sponsored by the Biotechnology and Biological Sciences Research Council. Babraham Institute is headquartered in Cambridge, GB.

TrakCel Ltd. delivers a suite of integrated technologies to orchestrate the cell therapy supply chain for autologous and allogeneic therapies. The firm serves to medical centers, distribution and logistics clients, manufacturers, and therapy owners and trial sponsors/license holders. The company was founded in 2012 and is headquartered in Cardiff, the United Kingdom.